Cargando…

[(11)C]SCH23390 binding to the D(1)-dopamine receptor in the human brain—a comparison of manual and automated methods for image analysis

BACKGROUND: The D(1)-dopamine receptor radioligand [(11)C]SCH23390 has been frequently used in PET studies. In drug-naïve patients with schizophrenia, the findings have been inconsistent, with decreases, increases, and no change in the frontal cortex D(1)-dopamine receptors. While these discrepancie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stenkrona, Per, Matheson, Granville J., Cervenka, Simon, Sigray, Pontus Plavén, Halldin, Christer, Farde, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070454/ https://www.ncbi.nlm.nih.gov/pubmed/30069645 http://dx.doi.org/10.1186/s13550-018-0416-2

Ejemplares similares

Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
por: Plavén-Sigray, Pontus, et al.
Publicado: (2018)

D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
por: Stenkrona, Per, et al.
Publicado: (2019)

M7. LOWER THALAMIC DOPAMINE D2-RECEPTOR BINDING IN DRUG-NAIVE PATIENTS WITH PSYCHOSIS – A REPLICATION STUDY USING POSITRON EMISSION TOMOGRAPHY
por: Victorsson, Pauliina, et al.
Publicado: (2020)

Assessment of simplified ratio-based approaches for quantification of PET [(11)C]PBR28 data
por: Matheson, Granville J., et al.
Publicado: (2017)

Test-retest reliability and convergent validity of (R)-[(11)C]PK11195 outcome measures without arterial input function
por: Plavén-Sigray, Pontus, et al.
Publicado: (2018)

Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis
por: Plavén-Sigray, Pontus, et al.
Publicado: (2021)

Kinetic Modelling and Test–Retest Reproducibility for the Dopamine D(1)R Radioligand [(11)C]SCH23390 in Healthy and Diseased Mice
por: Bertoglio, Daniele, et al.
Publicado: (2020)

Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise
por: Matheson, Granville James, et al.
Publicado: (2019)

No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis
por: Lee, Maria, et al.
Publicado: (2021)

SCH23390 Reduces Methamphetamine Self-Administration and Prevents Methamphetamine-Induced Striatal LTD
por: Avchalumov, Yosef, et al.
Publicado: (2020)

The readability of scientific texts is decreasing over time
por: Plavén-Sigray, Pontus, et al.
Publicado: (2017)

Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men
por: Caravaggio, Fernando, et al.
Publicado: (2018)

PET imaging of [(11)C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
por: Varnäs, Katarina, et al.
Publicado: (2018)

Kinetic analysis and test-retest variability of the radioligand [(11)C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
por: Jučaite, Aurelija, et al.
Publicado: (2012)

Reliability of dopamine transporter PET measurements with [(18)F]FE-PE2I in patients with Parkinson’s disease
por: Kerstens, Vera S., et al.
Publicado: (2020)

Effects of SCH-23390 in Combination with a Low Dose of 17β-Estradiol on Anxiety-Like Behavior in Ovariectomized Rats
por: Fedotova, Julia
Publicado: (2014)

In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET study
por: Svensson, Jonas E., et al.
Publicado: (2022)

Meta-analytic studies of the glial cell marker TSPO in psychosis – a question of apples and pears?: A commentary on ‘Neuroinflammation in schizophrenia: metaanalysis of in-vivo microglial imaging’ by Marques et al.
por: Plavén-Sigray, P., et al.
Publicado: (2019)

Serotonin transporter availability increases in patients recovering from a depressive episode
por: Svensson, Jonas E., et al.
Publicado: (2021)

Kinfitr — an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability
por: Tjerkaski, Jonathan, et al.
Publicado: (2020)

Serotonin 5-HT(1A) receptor binding and self-transcendence in healthy control subjects—a replication study using Bayesian hypothesis testing
por: Griffioen, Gina, et al.
Publicado: (2018)

Test-retest reproducibility of [(11)C]-l-deprenyl-D(2) binding to MAO-B in the human brain
por: Arakawa, Ryosuke, et al.
Publicado: (2017)

SCH23390 and a humanized anti-cocaine mAb decrease the latency to cocaine-induced reinstatement of lever pressing behavior in rats that self-administer cocaine
por: Zinani, Dakota B., et al.
Publicado: (2023)

T7. UPDATED INDIVIDUAL PARTICIPANT DATA META-ANALYSIS CONFIRMS LOWER LEVELS OF THE GLIAL MARKER TSPO IN PSYCHOSIS PATIENTS
por: Plavén-Sigray, Pontus, et al.
Publicado: (2020)

Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data
por: Plavén-Sigray, Pontus, et al.
Publicado: (2018)

Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [(11)C]AZ10419369 Positron Emission Tomography Study
por: Tangen, Ämma, et al.
Publicado: (2022)

Comparison of D(2) dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects
por: Nord, Magdalena, et al.
Publicado: (2011)

Serotonin concentration enhancers at clinically relevant doses reduce [(11)C]AZ10419369 binding to the 5-HT(1B) receptors in the nonhuman primate brain
por: Yang, Kai-Chun, et al.
Publicado: (2018)

Effects of age, BMI and sex on the glial cell marker TSPO — a multicentre [(11)C]PBR28 HRRT PET study
por: Tuisku, Jouni, et al.
Publicado: (2019)

Effects of amphetamine on the human brain opioid system – a positron emission tomography study
por: Guterstam, Joar, et al.
Publicado: (2013)

GABA(A) receptor occupancy by subtype selective GABA(Aα2,3) modulators: PET studies in humans
por: Jucaite, Aurelija, et al.
Publicado: (2016)

Quantification and reliability of [(11)C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung — a test-retest PET study in control subjects
por: Cselényi, Zsolt, et al.
Publicado: (2020)

Simulations to benchmark time-varying connectivity methods for fMRI
por: Thompson, William Hedley, et al.
Publicado: (2018)

PET Evaluation of the Novel F-18 Labeled Reversible Radioligand [(18)F]GEH200449 for Detection of Monoamine Oxidase-B in the Non-Human Primate Brain
por: Varnäs, Katarina, et al.
Publicado: (2023)

Fenfluramine Reduces [(11)C]Cimbi-36 Binding to the 5-HT(2A) Receptor in the Nonhuman Primate Brain
por: Yang, Kai-Chun, et al.
Publicado: (2017)

High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
por: Fazio, Patrik, et al.
Publicado: (2020)

Thinking Outside a Less Intact Box: Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals
por: de Manzano, Örjan, et al.
Publicado: (2010)

Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder
por: Lundberg, Johan, et al.
Publicado: (2012)

Detection of amyloid in Alzheimer’s disease with positron emission tomography using [(11)C]AZD2184
por: Nyberg, Svante, et al.
Publicado: (2009)

Early stopping in clinical PET studies: How to reduce expense and exposure
por: Svensson, Jonas E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fhunb05ptkiuf9e689dnh7u115